Sales of devices slowed earlier this year because many elective hip and knee procedures were being postponed in the face of lost insurance coverage, high out-of-pocket charges or inability to take time off from work.
However, recent quarterly reports from Zimmer Holdings, Stryker Corp. and Johnson & Johnson have shown a modest improvement in sales.
Read Dow Jones Newswires’ report on the joint replacement market.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
